| To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer (NCT07647744) | Hrain Biotechnology Co., Ltd. | 2026-06-30 |
| To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL (NCT06045091) | Hrain Biotechnology Co., Ltd. | 2023-07-04 |
| To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL (NCT05651191) | Hrain Biotechnology Co., Ltd. | 2022-10-21 |
| Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients (NCT05651178) | Hrain Biotechnology Co., Ltd. | 2022-08-12 |
| Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM (NCT05594797) | Hrain Biotechnology Co., Ltd. | 2022-07-12 |
| To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL. (NCT05223686) | Hrain Biotechnology Co., Ltd. | 2022-02-10 |
| To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM (NCT05302648) | Hrain Biotechnology Co., Ltd. | 2022-02-09 |
| Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia (NCT06760260) | Hrain Biotechnology Co., Ltd. | 2022-01-26 |
| Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma (NCT05436223) | Hrain Biotechnology Co., Ltd. | 2021-08-09 |
| BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma (NCT03943472) | Hrain Biotechnology Co., Ltd. | 2019-07-08 |
| Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma (NCT04003168) | Hrain Biotechnology Co., Ltd. | 2019-07-01 |
| Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia (NCT03798509) | Hrain Biotechnology Co., Ltd. | 2019-03-13 |
| Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES (NCT03879382) | Hrain Biotechnology Co., Ltd. | 2019-02-27 |
| Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma. (NCT03720457) | Hrain Biotechnology Co., Ltd. | 2018-11-13 |